Ovulai AB

Ovulai AB is a Swedish company focused on enhancing the lives of individuals affected by Polycystic Ovary Syndrome (PCOS) through a dedicated mobile application that offers tailored support and resources. Founded in 2020, Ovulai AB specializes in developing a mobile application for individuals diagnosed with PCOS. The company is based in Stockholm, Sweden, and has completed one funding round. The most recent deal, dated June 1, 2022, involved raising an undisclosed amount from KTH Holding.

The founder's history is currently not available. Ovulai offers a specialized mobile application designed for individuals diagnosed with Polycystic Ovary Syndrome (PCOS). The app provides evidence-based knowledge, support, and guidance tailored to meet the specific needs of those living with this condition. Key functionalities include symptom tracking, access to educational content created by healthcare experts, and a community platform for users to connect and share experiences.

The application aims to fill a significant gap in healthcare services for women dealing with chronic conditions, starting with PCOS and expanding to other gynecological disorders in the future. Currently, the app is available in Sweden and serves a broad user base of women affected by PCOS, with plans to introduce additional offerings for other chronic conditions as the product develops. Ovulai generates revenue primarily through subscription-based models for its app services. Users can access a free trial for seven days, after which they can choose from various subscription plans, including a standard monthly plan priced at 149 SEK and a quarterly plan available for 359 SEK.

The premium subscriptions grant users access to additional resources such as personalized health programs, individual health advice, and direct queries to medical experts. The app's structure supports direct-to-consumer transactions, allowing users to subscribe online and receive tailored support for managing their PCOS. Such a business model facilitates recurring revenue, ensuring consistent engagement with their user base while providing valuable health management tools. Ovulai plans to enhance its product offerings and expand its market reach.

New features for the application are being designed to improve user experience and will be rolled out in the upcoming quarters. The company aims to extend its services beyond Sweden, targeting markets across Europe by the end of 2023. The recent funding raised in June 2022 will be utilized to support these development initiatives and facilitate market entry into new regions.